Benefits & evidence
Evaluate Clarrio.ai program benefits with evidence appropriate to each decision
Understand what a longitudinal workflow can contribute to a care or research program, what each person receives, and which evidence is needed to evaluate the result.
Payers × users
How payer and user priorities differ across industries
Payers assess relevance, service delivery and evidence at population level. Patients, members and caregivers need meaningful reporting and a clear review pathway. Compare how those priorities change across care and research settings.
Illustrative scenario · not a customer result
A member shares routine changes and available home observations between scheduled program reviews
Payers & funders
Patients, members & caregivers
- 01Define eligibility and the funded service
- 02Review reach, follow-up and access
- 03Appraise separately measured outcomes
- 01Agree a personal review goal
- 02Add routine context and observations
- 03Discuss the dated interval with the team
What both perspectives share
Both perspectives need dated observations, clear source labels and an accessible participation pathway. The member's personal review and the funder's population evaluation serve different purposes.
Illustrative scenario · not a customer result
A patient-support program collects reports of everyday function alongside appropriately scoped clinical records
Payers & funders
Patients, members & caregivers
- 01Specify population and relevant comparator
- 02Assess source quality and missingness
- 03Review the evidence with HEOR experts
- 01Understand the program and permitted uses
- 02Contribute appropriately scoped reports
- 03Bring concerns to the designated contact
What both perspectives share
Both need a meaningful question and an appropriate reporting instrument. Individual support, research analysis and payer appraisal require distinct purposes and permitted uses.
Illustrative scenario · not a customer result
A distributed study collects scheduled patient reports across sites and reconciles missing observation windows before analysis
Payers & funders
Patients, members & caregivers
- 01Check relevance of the study population
- 02Inspect collection methods and follow-up
- 03Review analysis limitations and transferability
- 01Review the study schedule and support
- 02Report within agreed collection windows
- 03Resolve questions with the study team
What both perspectives share
Both need protocol-consistent collection and transparent gaps. A payer is usually a downstream evidence reviewer, not the participant's study contact or the operator of the collection workflow.
Illustrative scenario · not a customer result
A follow-up service combines patient-reported experience and available home observations before the next encounter
Payers & funders
Patients, members & caregivers
- 01Define the service and evaluation horizon
- 02Review reach, equity and service delivery
- 03Evaluate linked outcomes against a suitable comparison
- 01Agree reports and response expectations
- 02Share experience and home observations
- 03Discuss next steps through the service pathway
What both perspectives share
Both need an accountable service: a defined population, responsible review team and non-digital options. More incoming observations are useful only when the service can act on its agreed review process.
Evaluation foundations
Four questions for evaluating a longitudinal health data program
01
Which decision needs better context?
Define the population, review window and question before selecting data. A clinician preparing an encounter, a researcher describing function and a payer appraising a service need different evidence. Start with the decision rather than the number of connected sources.
02
What does each observation mean?
Keep patient reports, device-derived observations and clinical records distinguishable. Preserve dates, units, recall periods and source methods. An empty reporting window is not a normal result, and two similar-looking values may not be comparable.
03
Who turns the record into a next step?
Agree review ownership, reporting cadence, support and handoffs. Data collection without a responsible review process can create more work without helping the person contributing it. Care and research pathways need explicit boundaries and contact arrangements.
04
What evidence would support a benefit?
Separate operational coverage, patient experience, clinical outcomes and economic endpoints. Define baselines and relevant comparisons before evaluation. More complete data or higher participation does not by itself demonstrate better health, reduced utilization or financial savings.
Benefits in practice
Benefits for every participant in the program
Longevity clinics
Make the program review about the interval, not just the latest result
An annual assessment and a wearable dashboard answer different questions. The assessment describes a scheduled measurement; a device records selected aspects of everyday life. Neither alone explains whether a member could sustain a routine, why observations stopped or what they want to discuss. Combining them is useful only when the dates, measurement methods and member context remain distinguishable.
01
Agree a review question
Choose a specific interval and member goal rather than collecting every available signal.
02
Build the dated record
Use the Patient App for member context, the Platform for available source coverage and Intelligence for source-aware review.
03
Prepare the conversation
Compare like-for-like observation windows, inspect gaps and bring unresolved questions to the physician or coach.
For the professional team
Physicians and coaches gain a structured basis for preparation: which period changed, which source supports the observation and which question remains open. Leadership can separately review onboarding, connection support and review workload. A more detailed chart does not establish that the program improved health or extended life.
For patients, members and caregivers
Members can explain travel, routines and personal priorities alongside their observations. The benefit is continuity of the conversation, not another unexplained score. A useful member journey also makes room for people without a wearable and makes clear when the team will review what they share.
For payers and program funders
For an employer or payer considering a preventive program, participation and data coverage are starting points, not evidence of prevention or savings. Define the eligible population, program services and evaluation period before comparing results. A self-pay clinic membership does not imply an insurance coverage benefit.
- Review period
- Assessment dates and available between-visit observations
- Source context
- Device type, lab units and member-reported routine changes
- Unresolved question
- What should the member and team discuss at the next review?
Workflow illustration · not a customer result or live record
What to evaluate before making a claim
Track whether intended records are available, whether reviews are completed and whether members find the reporting burden acceptable. Analyze renewals separately from health outcomes; neither should be attributed to a software workflow without a suitable evaluation.
Explore evidence and evaluationPharma & biotech
Start with the evidence question a decision-maker actually needs answered
Routine records can describe encounters and prescriptions while leaving daily function, symptom burden and experience under-observed. Adding remote data can fill selected gaps, but a large dataset is not automatically decision-ready. Population selection, questionnaire suitability, exposure timing and missing observations can all change the interpretation of a longitudinal analysis.
01
Specify the evidence objective
Define the population, observation window, outcome concept and intended decision before selecting sources.
02
Collect and reconcile
Combine appropriately scoped Patient App reports with available clinical and device data in the Platform; keep reported experience separate from recorded events.
03
Review before analysis
Use source-aware review to inspect context and quality. Agree variable definitions, analysis methods and limitations with the study team.
For the professional team
Clinical development, medical affairs and HEOR teams can work from a common record while asking different questions. Clinical operations needs coverage by site and timepoint; an evidence analyst needs definitions and provenance; medical affairs needs an account of the population and study limitations. Those outputs should not be treated as interchangeable.
For patients, members and caregivers
Participants have a structured way to contribute the experience that encounters may miss. Questions should be meaningful, proportionate and appropriate to the population. Explain the study purpose, who reviews submissions and whether reporting receives an individual response; a research diary is not an emergency service.
For payers and program funders
A payer-facing evidence package should connect patient experience to a defined decision question and relevant population. Include baseline characteristics, follow-up, missingness and the analysis method. Patient-reported experience can complement other evidence, but it does not alone establish comparative effectiveness, economic value or a coverage recommendation.
- Population definition
- Eligibility, enrollment dates and relevant baseline characteristics
- Longitudinal variables
- Source, units, assessment window and missing-data conventions
- Evidence limitations
- Selection, confounding and generalisability to the decision population
Workflow illustration · not a customer result or live record
What to evaluate before making a claim
Assess suitability against the research question: provenance, completeness, accuracy and relevance. Predefine the analysis rather than choosing a favorable pattern after viewing the results. Publication and payer use require appropriate scientific review.
Explore evidence and evaluationCROs & research teams
Make remote collection operationally accountable across sites
A participant may be enrolled but not connected, connected but not reporting, or reporting outside the intended window. Treating all three situations as one completion measure hides different operational problems. Distributed studies need clear responsibility for connection support, participant contact and data queries, alongside a protocol that defines what should be collected.
01
Translate the protocol
Map each requested observation to a source, collection window and responsible study role.
02
Inspect site coverage
Review available Platform records by participant, site and timepoint; distinguish technical gaps from missed questionnaire windows.
03
Resolve and document
Route issues to the agreed study owner and preserve the context of any correction before producing sponsor-agreed outputs.
For the professional team
Study managers can discuss a specific missing source rather than a generic incomplete record. Data managers can reconcile dates and definitions before analysis. Site teams need a manageable contact process that fits the protocol, not an additional dashboard with no assigned owner. Integration and export requirements belong in the study scope.
For patients, members and caregivers
Participants benefit from a predictable reporting schedule and a clear contact for technical or study questions. Reduce duplicate questions where possible and review whether device access, language or caregiver support affects participation. Remote collection should supplement the protocol, not silently remove necessary visits.
For payers and program funders
When study outputs will later support HEOR or payer appraisal, preserve the link from collection methods to the evidence question. Transparent follow-up and source quality help reviewers understand the dataset, but improved operational completion does not prove that a study conclusion is unbiased.
- Collection plan
- Source and expected window for each protocol observation
- Issue review
- Missing source, affected window and responsible study role
- Sponsor handoff
- Defined variables with reconciliation notes and known limitations
Workflow illustration · not a customer result or live record
What to evaluate before making a claim
Separate enrollment, connection availability, valid observations and scheduled report completion. Compare sites only with denominators and follow-up windows that make the comparison meaningful. Document reasons for gaps where available rather than imputing normal values.
Explore evidence and evaluationHospitals & health systems
Connect the encounter to a follow-up process with an owner
An encounter record captures what happened in the service, not every aspect of life afterwards. A patient may face a device problem, a reporting burden or uncertainty about who will respond. More incoming data will not resolve those problems unless the service defines review responsibility, contact pathways and the boundary between routine follow-up and urgent care.
01
Choose the service window
Define the patient group and between-encounter questions the team can realistically review.
02
Add patient context
Use scoped Patient App reports alongside available records and home observations; review source gaps in the Platform.
03
Close the handoff
Prepare a source-aware summary for the responsible team and use the service's established follow-up and escalation procedures.
For the professional team
Clinicians can review the interval before an appointment; care managers can distinguish a stopped data feed from an unanswered report. Operational leaders need to understand who performs that review and what workload it creates. Clarrio.ai should be scoped alongside the existing system of record, not assumed to replace it.
For patients, members and caregivers
Patients can share everyday experience without having to reconstruct an entire interval at the next encounter. They also need clarity about response times, access support and what to do when urgent help is needed. A non-digital participation pathway matters for people whose devices, connectivity or circumstances make remote reporting difficult.
For payers and program funders
For a funded follow-up service, evidence should describe both reach and the service delivered. Reporting activity is not a readmission outcome, and a more complete record is not proof of lower utilization. Any comparison of service use needs linked outcome data, appropriate follow-up and a credible design.
- Pre-visit context
- Dated patient reports and available home observations
- Coverage review
- Source interruption distinguished from an unanswered report
- Handoff question
- Named review responsibility and the next service conversation
Workflow illustration · not a customer result or live record
What to evaluate before making a claim
Review reach, reporting burden, follow-up completion and staff workload alongside the service's intended outcomes. Examine participation across relevant patient groups so an apparently successful digital pathway does not conceal unequal access.
Explore evidence and evaluationPayers & health economics
Distinguish richer patient context from evidence of value
Claims and encounter datasets can describe recorded utilization without fully capturing function, experience or the practical burden of a program. Patient reports add a different perspective, but they can be incomplete or drawn from a population unlike the members covered by a payer. The task is to establish whether those observations are suitable for a specific appraisal question, not to turn engagement into a savings claim.
01
Define the appraisal question
Specify the relevant covered population, decision, comparator where needed and evaluation horizon.
02
Assess data suitability
Review provenance, participation, measurement windows and missingness before examining results.
03
Build the evidence account
Combine appropriately governed patient experience with relevant clinical or utilization evidence; document assumptions and limits for expert appraisal.
For the professional team
HEOR and population-health teams can examine how reported experience varies across the observation period and which groups are represented. A useful output explains the denominator behind a measure and the observations excluded from analysis. Governance must also define the permitted purpose of any linkage to payer-held data.
For patients, members and caregivers
The member perspective should remain visible in a program evaluation: burden, everyday function, access and what participants consider meaningful. Reporting should not become an unexplained condition of receiving services. Explain the collection purpose and permitted uses in a way members can understand.
For payers and program funders
Decision support means an inspectable evidence package, not an automatic reimbursement verdict. Include the target population, relevant baseline differences, data sources, follow-up and limitations. Cost and utilization conclusions need appropriate data and analysis; neither can be inferred from app activity or observation coverage.
- Decision context
- Population, appraisal question and evaluation horizon
- Suitability account
- Provenance, completeness, accuracy and relevance
- Interpretation boundary
- What the analysis can support and what remains uncertain
Workflow illustration · not a customer result or live record
What to evaluate before making a claim
Separate program participation, patient-reported experience, clinical outcomes and economic endpoints. Define each before collection, use an appropriate comparison where the question requires one and examine whether findings transfer to the covered population.
Explore evidence and evaluationPatients, members & caregivers
Give the person contributing data a meaningful place in the workflow
A person can complete many questions without understanding why they are being asked or who will read the answers. Device observations may look precise while missing personal context. A useful longitudinal journey starts with the person's priorities and makes the reporting purpose, burden and review arrangements understandable.
01
Explain the purpose
Agree what the care or research program needs to learn and what participation involves.
02
Capture lived experience
Use appropriate reports alongside available observations; distinguish the patient's own answers from caregiver observations.
03
Bring context to review
Discuss a dated interval with the responsible professional, including what is missing and what matters to the person.
For the professional team
Teams gain context for a more specific conversation, but should not assume that a missed report means a person disengaged. Accessibility, fatigue, language and connectivity may affect reporting. Define support and review arrangements before introducing new questions.
For patients, members and caregivers
Patients and members can keep a dated account of experiences they might otherwise forget. Caregivers can contribute observations when appropriately scoped, without replacing the person's own perspective. Personal patterns invite discussion; they are not instructions or proof that a particular routine produced an outcome.
For payers and program funders
A program's apparent reach can hide who could not participate. Payers and commissioners should examine access, reporting burden and representativeness alongside outcome evidence. Patient experience is an important perspective in appraisal, not a shortcut to an economic conclusion.
- Personal context
- The person's own priorities and dated reports
- Reporting perspective
- Patient answer or appropriately identified caregiver observation
- Review arrangement
- Who reviews reports, when and through which contact pathway
Workflow illustration · not a customer result or live record
What to evaluate before making a claim
Ask whether reporting is understandable, manageable and meaningful. Examine completion alongside accessibility and support needs. A high completion rate alone does not show that people feel heard or that a program has improved their health.
Explore evidence and evaluationFurther reading
The principles behind an evidence-ready record
These public sources inform the evaluation principles discussed here. They are not endorsements of Clarrio.ai or evidence of its results.
- NICE · assessing data suitability
Provenance, quality and relevance to the research question and population.
- EMA · registry-based studies
Study planning, population definition, data collection, quality and analysis.
- FDA · patient-reported outcome measures
Choosing measures appropriate to their intended context of use; this guidance concerns medical-product labeling claims.
- WHO · digital interventions for health systems
Implementation alongside functioning services, with attention to feasibility, acceptability and equity.
Request a demo
Explore disease, treatment and behavior together
Explore how clinical, treatment and behavioral information align around your program and the research or review questions your team needs to answer.
Opens the Calendly booking page in a new tab.
Prefer to write first? Send an inquiry and the team will reply.